17h
Investor's Business Daily on MSNWhy IBD Stock Of The Day Quest Diagnostics Sidestepped The Sell-OffQuest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling ...
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors despite daily gains
Quest Diagnostics Inc. closed 4.61% short of its 52-week high of $178.87, which the company reached on March 10th.
Quest Diagnostics Incorporated's ( NYSE:DGX ) dividend will be increasing from last year's payment of the same ...
The most recent lawsuit is from winter 2024, when the California attorney general announced a $5 million settlement with ...
2don MSN
The price of the deal was disclosed for the first time in bond filings, showing how it helped flip a net operating loss last ...
1d
Fintel on MSNRedburn Atlantic Initiates Coverage of Quest Diagnostics (DGX) with Buy RecommendationFintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...
Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...
Dozens of healthcare providers descended on the Legislative Office Building Thursday, with a united message: increase ...
Quest Diagnostics teamed up with Google Cloud. The collaboration seeks to deliver new AI capabilities — including predictive ...
Readers hoping to buy Quest Diagnostics Incorporated (NYSE:DGX) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one business ...
Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report first quarter 2025 financial results on Tuesday, April 22, 2025, before the ...
This was the stock's second consecutive day of gains.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results